| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0121-4950-40 | 0121-4950 | HUMAN PRESCRIPTION DRUG | Lidocaine Hydrochloride | Lidocaine Hydrochloride | SOLUTION | ORAL | 20240220 | N/A | ANDA | ANDA218138 | PAI Holdings, LLC | LIDOCAINE HYDROCHLORIDE ANHYDROUS | 20 mg/mL | 4 TRAY in 1 CASE (0121-4950-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE (0121-4950-15) |
| 0121-0950-03 | 0121-0950 | HUMAN PRESCRIPTION DRUG | Lidocaine Hydrochloride | Lidocaine Hydrochloride | SOLUTION | ORAL | 20240220 | N/A | ANDA | ANDA218138 | PAI Holdings, LLC | LIDOCAINE HYDROCHLORIDE ANHYDROUS | 20 mg/mL | 12 BOTTLE in 1 CASE (0121-0950-03) / 100 mL in 1 BOTTLE |